Reduction of stroke risk in those with transient ischaemia of the brain or completed ischaemic stroke due to thrombosis.



  • Adult: By mouth: May be taken with or without food. Swallow whole, do not chew/crush.
    • Per cap contains aspirin 25 mg and extended-release dipyridamole 200 mg: 1 cap twice daily.
  • Should not be used in patients with the following conditions
    • Hypersensitivity, allergy to NSAIDs, bleeding disorders (factor VII or IX deficiencies), asthma, rhinitis or nasal polyps, children <16 yr with viral infections.
  • Caution for use in patients with Unstable angina, recent MI, subaortic stenosis, severe coronary artery disease, hypotension, history of peptic ulcer disease, inherited or acquired bleeding disorders. Admin of dipyridamole may cause increase in hepatic enzymes and hepatic failure.
  • If you are planning to be pregnant or think you may be pregnant, discuss the risks and benefits of use with your doctor.
  • Before breast-feeding, consult your physician.

GI disturbances, dyspepsia, abdominal pain, nausea, diarrhoea, vomiting, epigastric discomfort, rhinitis, urticaria, prolonged bleeding time, headache, dizziness, facial flushing, fainting, skin rash. Body pain, allergic reaction, fever, hypotension, tachycardia, palpitation, arrhythmia, hyperglycaemia, thirst, agitation, uterine haemorrhage, taste loss.

If overdose is suspected, contact a poison control center or emergency room immediately. Symptoms may include:

  • warm feeling
  • flushing
  • sweating
  • restlessness
  • feeling of weakness
  • dizziness
  • tinnitus



Store at 25°C

Related Articles

Vaccine, DTP

DTP vaccine (Diphtheria and Tetanus toxoids and Pertussis adsorbed vaccine) is a combination vaccine used to induce specific antibody production, thus promoting immunity [...]


Teicoplanin is a glycopeptide antibiotic drug that inhibits the growth of susceptible organisms by disrupting cell-wall synthesis. It binds to D-alanyl-D-alanine residues resulting to peptidoglycan synthesis blockage. Use this [...]


Secukinumab is a human monoclonal antibody, Immunoglobulin G1/K that binds selectively to interleukin-17A (IL-17A), a natural cytokine affecting normal inflammatory and immune responses. It inhibits the release [...]